Duidelijkheid na samenvoegen van studies

A. De Boer

Duidelijkheid na samenvoegen van studies

Translated title of the contribution: Clarity after combination studies: COPD medication is safe for the heart and the vessels

A. De Boer

Pharmacoepidemiology and Clinical Pharmacology

Research output: Contribution to journal › Special issue › Professional

Translated title of the contribution	Clarity after combination studies: COPD medication is safe for the heart and the vessels
Original language	Dutch
Pages (from-to)	22-25
Number of pages	4
Journal	Pharmaceutisch Weekblad
Volume	143
Issue number	50
Publication status	Published - 12 Dec 2008

Keywords

beta adrenergic receptor stimulating agent
cholinergic receptor blocking agent
corticosteroid
ipratropium bromide
tiotropium bromide
blood vessel
cardiovascular risk
chronic obstructive lung disease
clinical trial
drug safety
heart
heart infarction
human
ischemic heart disease
short survey
thromboembolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{ab192453e2c645838271f2dca27157f7,

title = "Duidelijkheid na samenvoegen van studies",

keywords = "beta adrenergic receptor stimulating agent, cholinergic receptor blocking agent, corticosteroid, ipratropium bromide, tiotropium bromide, blood vessel, cardiovascular risk, chronic obstructive lung disease, clinical trial, drug safety, heart, heart infarction, human, ischemic heart disease, short survey, thromboembolism",

author = "{De Boer}, A.",

year = "2008",

month = dec,

day = "12",

language = "Dutch",

volume = "143",

pages = "22--25",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "50",

}

TY - JOUR

T1 - Duidelijkheid na samenvoegen van studies

AU - De Boer, A.

PY - 2008/12/12

Y1 - 2008/12/12

KW - beta adrenergic receptor stimulating agent

KW - cholinergic receptor blocking agent

KW - corticosteroid

KW - ipratropium bromide

KW - tiotropium bromide

KW - blood vessel

KW - cardiovascular risk

KW - chronic obstructive lung disease

KW - clinical trial

KW - drug safety

KW - heart

KW - heart infarction

KW - human

KW - ischemic heart disease

KW - short survey

KW - thromboembolism

M3 - Special issue

SN - 0031-6911

VL - 143

SP - 22

EP - 25

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 50

ER -